Pharmaceutical Gelatin Market Report 2026

The pharmaceutical gelatin market size has grown strongly in recent years. It will grow from $1.37 billion in 2025 to $1.45 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to limited production capacities, growing pharmaceutical manufacturing, rising awareness of gelatin benefits, preference for natural excipients, regional production hubs in europe and north america.

The pharmaceutical gelatin market size is expected to see strong growth in the next few years. It will grow to $1.86 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to expanding pharmaceutical applications, rising demand in emerging markets, technological advancements in gelatin extraction, increased adoption in nutraceuticals, innovation in alternative gelatin sources. Major trends in the forecast period include increasing demand for hard and soft gel capsules, rising adoption of pharmaceutical gelatin in absorbable hemostats, growth in bovine and porcine gelatin production, expansion of marine and poultry gelatin sources, stringent regulatory compliance and quality standards.

The rising demand for health and wellness is projected to drive expansion in the pharmaceutical gelatin market. Health and wellness refer to a comprehensive strategy for total well-being, spanning physical, mental, and social dimensions of health. Pharmaceutical gelatin supports health and wellness by enabling safe and efficient drug delivery, enhancing the efficacy of certain medications and minimizing the frequency of doses. For instance, in January 2024, Wellness Creative Co, a UK-based wellness firm, reported that the health and wellness industry is forecasted to hit $7.2 trillion by 2025, with an annual growth rate of 8.5%. Thus, the growing demand for health and wellness is fueling the pharmaceutical gelatin market's expansion.

Major companies in the pharmaceutical gelatin market are rolling out advanced solutions like Easyseal gelatin to cut production costs linked to soft gel leakers. Easyseal tackles this challenge through optimized seam formation, thicker and more stable seams, which make soft capsules tougher against physical stress and reduce leaker issues. For example, in December 2023, GELITA MEDICAL GmbH - a Germany-based producer of gelatin and collagen peptides for food, health, nutrition, and pharmaceutical sectors - introduced Easyseal gelatin. This innovation shows less reliance on sealing temperature than other gelatins and offers better drying performance. It boosts energy efficiency and lifts overall production capacity. The product enables manufacturers to seal capsules reliably at high speeds, particularly with hard-to-fill suspensions. It shines especially in making products that need specialized equipment, like double-step die tooling.

In April 2023, Darling Ingredients Inc., a U.S.-based producer of animal feed, purchased Gelnex Gelatin for an undisclosed sum. This acquisition provides Darling Ingredients with instant production capabilities to satisfy the rising needs of its collagen clients and positions the company strongly to address the increasing market for gelatin and collagen. Gelnex Gelatin, based in Brazil, specializes in manufacturing gelatin and collagen products for pharmaceutical applications.

Major companies operating in the pharmaceutical gelatin market are Nitta Gelatin Inc., Lonza Group AG, Darling Ingredients Inc., Catalent Inc., Tessenderlo Group NV, Gelita AG, Rousselot Inc., Weishardt & Co. KG, Batotau Dongbao Bio-Tech, Nippi Collagen Co. Ltd., Apex Pharma Ltd., Narmada Gelatines Ltd., Aspire Pharmaceuticals Pvt. Ltd., Sterling Gelatin Limited, Junca Gelatines SL, Trobas Pharmaceutical gelatine B.V., Gelco International, Reichert Gruppe Ingredients GmbH, Norland Products Inc., Lapi Gelatine S.p.a., Italgelatine S.p.A, Kenney & Ross Limited, Xiamen Yasin industry & Trade Co. Ltd., PB Gelatins SA.

North America was the largest region in the pharmaceutical gelatin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical gelatin market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pharmaceutical gelatin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the pharmaceutical gelatin market by increasing the cost of raw materials imported from major animal collagen-producing regions, causing disruptions in the supply chain and raising production costs. Segments such as hard and softgel capsules, absorbable hemostats, and specialty gelatin types are most affected, especially in regions like asia-pacific and europe that rely heavily on imports. While the tariffs create cost challenges, they also encourage local sourcing, domestic production, and investment in alternative gelatin sources, which can enhance supply chain resilience and innovation in the market.

The pharmaceutical gelatin market research report is one of a series of new reports that provides pharmaceutical gelatin market statistics, including pharmaceutical gelatin industry global market size, regional shares, competitors with a pharmaceutical gelatin market share, detailed pharmaceutical gelatin market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical gelatin industry. This pharmaceutical gelatin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Pharmaceutical gelatin refers to a specialized form of gelatin manufactured for pharmaceutical and medical uses. Derived from collagen - a protein present in animal connective tissues - it undergoes rigorous purification to satisfy stringent safety and quality requirements. It serves to create an effective barrier against light, moisture, and oxygen.

The primary types of pharmaceutical gelatin are type A and type B. Type A denotes gelatin manufactured via the acid process, entailing the hydrolysis of collagen under acidic conditions. It serves functions like stabilizer, thickener, gelling agent, and more, derived from sources including porcine, bovine skin, bovine bone, marine, and poultry. These are applied in hard capsules, soft gel capsules, tablets, absorbable hemostats, and others.

The pharmaceutical gelatin market consists of sales of pharmaceutical gelatin sourced from cattle bones, natural and marine sources gelatin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.